1. Capecitabine and temozolomide (CAPTEM) is effective in metastatic well‐differentiated gastrointestinal neuroendocrine tumors. Issue 8 (8th September 2022) Authors: Dogan, Izzet; Tastekin, Didem; Karabulut, Senem; Sakar, Burak Journal: Journal of digestive diseases Issue: Volume 23:Issue 8/9(2022) Page Start: 493 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Does nutritional status affect treatment tolarability, response and survival in metastatic colorectal cancer patients? Results of a prospective multicenter study. (August 2021) Authors: Karabulut, Senem; Dogan, Izzet; Usul Afsar, Cigdem; Karabulut, Mehmet; Karaman, Sule; Ferhatoglu, Ferhat; Tastekin, Didem Journal: Journal of oncology pharmacy practice Issue: Volume 27:Number 6(2021) Page Start: 1357 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Does nutritional status affect treatment tolerability, chemotherapy response and survival in metastatic gastric cancer patients? Results of a prospective multicenter study in Turkey. (January 2022) Authors: Karabulut, Senem; Dogan, Izzet; Usul Afsar, Cigdem; Karabulut, Mehmet; Ak, Naziye; Duran, Ali; Tastekin, Didem Journal: Journal of oncology pharmacy practice Issue: Volume 28:Number 1(2022) Page Start: 127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Evaluation of clinicopathological features determining treatment response in patients with ALK mutant NSCLC. Issue 34 (26th August 2022) Authors: Dogan, Izzet; Gurbuz, Mustafa; Paksoy, Nail; Ferhatoglu, Ferhat; Vatansever, Sezai; Saip, Pinar; Demirkazik, Ahmet; Aydiner, Adnan Journal: Medicine Issue: Volume 101:Issue 34(2022) Page Start: e30188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The effectiveness and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early-stage human epidermal growth factor receptor 2-positive breast cancer: Turkish Oncology Group study. Issue 7 (20th June 2022) Authors: Özdemir, Özlem; Zengel, Baha; Yildiz, Yaşar; Uluç, Basak Oyan; Cabuk, Devrim; Ozden, Ercan; Salim, Derya Kivrak; Paydas, Semra; Demir, Atakan; Diker, Omer; Pilanci, Kezban Nur; Sönmez, Özlem Uysal; Vatansever, Sezai; Dogan, Izzet; Gulmez, Ahmet; Cakar, Burcu; Gursoy, Pinar; Yildirim, Mahmut Emre;... Journal: Anti-cancer drugs Issue: Volume 33:Issue 7(2022) Page Start: 663 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The frequency and prognostic significance of ABO/Rh blood groups in male breast cancer patients: A multicenter study. Issue 35 (2nd September 2022) Authors: Dogan, Izzet; Ayhan, Murat; Gurbuz, Mustafa; Kucukarda, Ahmet; Aydin, Esra; Urun, Yuksel; Cicin, Irfan; Saip, Pinar Journal: Medicine Issue: Volume 101:Issue 35(2022) Page Start: e30147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗